Regina M. Paglia - Jun 15, 2021 Form 4 Insider Report for Dicerna Pharmaceuticals Inc (DRNA)

Signature
/s/ Douglas W. Pagan, attorney-in-fact
Stock symbol
DRNA
Transactions as of
Jun 15, 2021
Transactions value $
-$602,596
Form type
4
Date filed
6/17/2021, 09:18 PM
Previous filing
Jun 3, 2021
Next filing
Jun 22, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DRNA Common Stock Options Exercise +381 381 Jun 15, 2021 Direct F1
transaction DRNA Common Stock Tax liability -$4K -112 -29.4% $35.74 269 Jun 15, 2021 Direct F2
transaction DRNA Common Stock Options Exercise $259K +20K +7434.94% $12.93 20.3K Jun 16, 2021 Direct
transaction DRNA Common Stock Options Exercise $226K +10K +49.34% $22.58 30.3K Jun 16, 2021 Direct
transaction DRNA Common Stock Options Exercise $41.6K +1.56K +5.17% $26.62 31.8K Jun 16, 2021 Direct
transaction DRNA Common Stock Sale -$1.12M -31.5K -98.84% $35.63 369 Jun 16, 2021 Direct F3
transaction DRNA Common Stock Sale -$3.62K -100 -27.1% $36.15 269 Jun 16, 2021 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRNA Restricted Stock Units Options Exercise $0 -381 -24.98% $0.00 1.14K Jun 15, 2021 Common Stock 381 Direct F1, F4
transaction DRNA Employee Stock Option (Right to Buy) Options Exercise $0 -20K -16.21% $0.00 103K Jun 16, 2021 Common Stock 20K $12.93 Direct F5
transaction DRNA Employee Stock Option (Right to Buy) Options Exercise $0 -10K -16% $0.00 52.5K Jun 16, 2021 Common Stock 10K $22.58 Direct F6
transaction DRNA Employee Stock Option (Right to Buy) Options Exercise $0 -1.56K -22.92% $0.00 5.26K Jun 16, 2021 Common Stock 1.56K $26.62 Direct F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents the contingent right to receive one share of the Issuer's Common Stock.
F2 Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to cover tax withholding obligations in connection with the vesting of RSUs.
F3 The Reporting Person sold an aggregate of 31,564 shares of Common Stock on June 16, 2021 (the "Shares Sold") as reported in this Form 4. The Shares Sold represent 11.35% of 278,052 shares of Common Stock, which is the number of shares of Common Stock owned by the Reporting Person prior to the Shares Sold transaction reported in this Form 4, as well as shares issuable upon exercise or settlement of vested and unvested options and restricted stock units held by the Reporting Person as of the date of this report.
F4 Represents RSUs that vest over a period of four years, with 25% of the RSUs vesting on each of the first, second, third and fourth anniversaries of June 15, 2020, subject in each case to the Reporting Person's continued employment or service with the Issuer on each applicable vesting date.
F5 The option vested 25% on the first year anniversary of the vesting start date of February 19, 2019 and the remaining 75% vests in 36 substantially equal monthly installments thereafter, subject in each case to the Reporting Person's continued service with the Issuer through each applicable vesting date.
F6 The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of January 2020, and the remaining vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued service with the Issuer through each applicable vesting date.
F7 The option vests in 48 substantially equal monthly installments, with the first installment vesting on the last day of July 2020, and the remaining shares vesting on the last day of each of the 47 months thereafter; subject in each case to the Reporting Person's continued service with the Issuer through the applicable vesting date.